Severe Toxic Epidermal Necrolysis and Drug Reaction with Eosinophilia and Systemic Symptoms Overlap Syndrome Treated with Benralizumab: A Case Report
Case Reports in Dermatology
; 14(2):203-209, 2022.
Article
in English
| ProQuest Central | ID: covidwho-2027180
ABSTRACT
TEN/DRESS overlap syndrome can be difficult to diagnose, especially if it is masked by comorbidities in critically ill patients in intensive care units. The existing therapy for the two conditions is also a major challenge for the treating team. A possible alternative, especially for refractory cases, is benralizumab as an IL-5-receptor alpha-chain-specific humanized monoclonal antibody (IgG1k). We are able to show a successful treatment in this case report.
Medical Sciences--Dermatology And Venereology; Drug reaction with eosinophilia and systemic symptoms; Toxic epidermal necrolysis; Benralizumab; IL-5 blocker; Laboratories; Monoclonal antibodies; Patients; Severe acute respiratory syndrome coronavirus 2; Cytotoxicity; Liver; Mortality; Steroids; Biopsy; Lymphocytes; Severe acute respiratory syndrome; Skin; Inflammation; Conflicts of interest; Kidneys; Enzymes; Coronaviruses; Serology; Drug dosages; COVID-19
Search on Google
Collection:
Databases of international organizations
Database:
ProQuest Central
Type of study:
Case report
Language:
English
Journal:
Case Reports in Dermatology
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS